A study revealed that the LLC cell-derived exosomes exhibited a high level of EIF5A, and an upregulation of EIF5A expression was linked to a reduction in the overall survival of patients with lung cancer [77, 78]. The gene discussed is EIF5A; the disease is lung carcinoma.